Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 3/20 | 0.64 |
| ▸ | MAPT | P10636 | 1/20 | 0.64 |
| ▸ | PTGS2 | P35354 | 6/20 | 0.54 |
| ▸ | ALOX5 | P09917 | 5/20 | 0.54 |
| ▸ | MAOB | P27338 | 1/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.45 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.42 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | TTR | P02766 | 1/20 | 0.41 |
| ▸ | APP | P05067 | 1/20 | 0.41 |
| ▸ | ACHE | P22303 | 1/20 | 0.40 |
| ▸ | SYNJ2 | O15056 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | RECQL | P46063 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL683246 | 0.87 | CYP3A4 (0.56) | CYP3A4MAPTPTGS2ALOX5MAOB | |
| SCHEMBL69301 | 0.87 | CYP3A4 (0.56) | CYP3A4MAPTPTGS2ALOX5MAOB | |
| Methoxymethane SCHEMBL28032536 | 0.85 | CYP3A4 (0.54) | CYP3A4MAPTPTGS2ALOX5MAOB | |
| SCHEMBL14951058 | 0.84 | CYP3A4 (0.52) | CYP3A4MAPTPTGS2ALOX5MAOB | |
| SCHEMBL28618565 | 0.83 | CYP3A4 (0.47) | CYP3A4MAPTPTGS2ALOX5MAOB | |
| SCHEMBL28962160 | 0.80 | TTR (0.49) | CYP3A4MAPTMAOBMEN1KMT2A | |
| SCHEMBL70379 | 0.80 | ALOX5 (0.70) | CYP3A4MAPTPTGS2ALOX5MAOB | |
| SCHEMBL8064768 | 0.80 | CYP3A4 (0.67) | CYP3A4MAPTPTGS2ALOX5MAOB | |
| Antiarol SCHEMBL210578 | 0.78 | CYP3A4 (1.00) | CYP3A4MAPTPTGS2ALOX5MAOB | |
| Ethane SCHEMBL27660205 | 0.78 | ALOX5 (0.67) | CYP3A4MAPTPTGS2ALOX5MAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 329 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250367137-A1 | Phloroglucinol Formulations And Methods Of Use | CINPHLORO PHARMA LLC (US) | 2025-12-04 | — | — | US | claimed |
| US-20250177320-A1 | PHARMACEUTICAL FORMULATIONS OF PHLOROGLUCINOL AND TRIMETHYLPHLOROGLUCINOL | CINRX PHARMA, LLC (US) | 2025-06-05 | — | — | US | claimed |
| CN-120064530-A | Application of magnetic solid-phase dispersion extractant in detection of mycotoxin content in wheat | 南昌大学 | 2025-05-30 | — | — | CN | claimed |
| CN-119574738-A | Method for detecting related substances in trimethylphloroglucinol | 河北广祥制药有限公司 | 2025-03-07 | — | — | CN | claimed |
| CN-119367285-A | Preparation method and application of phloroglucinol injection | 北京科源创欣科技有限公司 | 2025-01-28 | — | — | CN | claimed |
| CN-119325372-A | Phloroglucinol formulations and methods of use | 辛菲特罗制药有限公司 | 2025-01-17 | — | — | CN | claimed |
| CN-119241339-A | Trimethyl room preparation method of phloroglucinol | 河北广祥制药有限公司 | 2025-01-03 | — | — | CN | claimed |
| CN-114583262-B | Electrolyte and lithium ion battery | 比亚迪股份有限公司 | 2024-10-11 | — | — | CN | claimed |
| CN-114890871-B | Preparation method of crude trimethylphloroglucinol and preparation method of trimethylphloroglucinol | 海口天行健药物研究有限公司 | 2024-09-17 | — | — | CN | claimed |
| CN-118615874-A | Preparation method and ion separation application of post-modified COF@dopamine composite membrane | 三峡大学 | 2024-09-10 | — | — | CN | claimed |
| CN-112535659-A | Preparation method of phloroglucinol injection | 南京艾德凯腾生物医药有限责任公司 | 2021-03-23 | — | — | CN | claimed |
| CN-112516077-A | Phloroglucinol injection and preparation method thereof | 万邦德制药集团有限公司 | 2021-03-19 | — | — | CN | claimed |
| CN-111840259-A | Injection of phloroglucinol and trimethyl phloroglucinol and preparation method thereof | 武汉人福药业有限责任公司 | 2020-10-30 | — | — | CN | claimed |
| WO-2018165404-A1 | PHARMACEUTICAL FORMUALTIONS OF PHLOROGLUCINOL AND TRIMETHYLPHLOROGLUCINOL | CINRX PHARMA, LLC (US) | 2018-09-13 | — | — | WO | claimed |
| US-20150150953-A1 | PHARMACEUTICAL COMPOSITION ADAPTED FOR ORAL ADMINISTRATION AND THE PROCESS FOR ITS PREPARATION, FOR THE PREVENTION AND TREATMENT OF IRRITABLE BOWEL SYNDROME, BASED ON AN INTESTINAL MOTILITY MODIFIER AND a-D-GALACTOSIDASE | POSI VISIONARY SOLUTIONS LLP (GB) | 2015-06-04 | — | — | US | claimed |
| EP-2790689-A1 | TREATMENT OF MIGRAINE HEADACHES, IN PARTICULAR CLUSTER HEADACHES | Pharmeuro (LU) | 2014-10-22 | — | — | EP | claimed |
| US-20130344145-A1 | ORALLY ADMINISTERED PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF IRRITABLE BOWEL SYNDROME, COMPRISING AN INTESTINAL MOTILITY MODIFIER, AN AGENT THAT PREVENTS GAS RETENTION, AND DIGESTIVE ENZYMES, AND PREPARATION METHOD THEREOF | POSI VISIONARY SOLUTIONS LLP (GB) | 2013-12-26 | — | — | US | claimed |
| EP-2641598-A2 | ORALLY ADMINISTERED PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF IRRITABLE BOWEL SYNDROME, COMPRISING AN INTESTINAL MOTILITY MODIFIER, AN AGENT THAT PREVENTS GAS RETENTION, AND DIGESTIVE ENZYMES, AND PREPARATION METHOD THEREOF | Posi Visionary Solutions LLP (GB) | 2013-09-25 | — | — | EP | claimed |
| EP-2641968-A2 | ORALLY ADMINISTERED PHARMACEUTICAL COMPOSITION AND PREPARATION METHOD THEREOF, FOR THE PREVENTION AND TREATMENT OF IRRITABLE BOWEL SYNDROME, COMPRISING AN INTESTINAL MOTILITY MODIFIER AND -D-GALACTOSIDASE | Posi Visionary Solutions LLP (GB) | 2013-09-25 | — | — | EP | claimed |
| WO-2013087410-A1 | TREATMENT OF MIGRAINE HEADACHES, IN PARTICULAR CLUSTER HEADACHES | PHARMEURO (LU) | 2013-06-20 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250367137-A1 | Phloroglucinol Formulations And Methods Of Use | MLN, HRH2, PYGM | CYP3A4 266/4885MAPT 1581/4885PTGS2 215/4885 |
| US-20250177320-A1 | PHARMACEUTICAL FORMULATIONS OF PHLOROGLUCINOL AND TRIMETHYLPHLOROGLUCINOL | SLC5A2, SLC5A1, LCT | CYP3A4 386/4885MAPT 559/4885PTGS2 2014/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.